Fig. 3.

No-Go false alarms. a RT and proportion error for No-Go false alarms for each group. b fMRI activity for No-Go false alarms during placebo averaged across groups (groups did not differ). Following memantine administration, fMRI activity reduced in a broad range of cortical, subcortical, and cerebellar regions relative to placebo in FHN (exemplified by the right graph); for FHP, fMRI activity reduced in a smaller number of (mostly subcortical) regions relative to placebo. As there were many ROIs showing a similar pattern of effects, an example is shown here and full presentation of results across all ROIs is given in the Supplementary material (Supplementary Fig. 2). All error bars show the standard error